CompletedNCT00393042
Official study titleSleep and Tolerability of Extended Release Dexmethylphenidate vs. Mixed Amphetamine Salts: A Double Blind, Placebo Controlled Study (SAT STUDY)
This study has finished and is no longer accepting participants.
Multiple locations, including ChicagoADHDMedication studyAges 9–17
- Countries
- United States
- Sponsor
- Seattle Children's Hospital
TerminatedNCT00885560
Official study titleDo People With ADHD, Who Respond Well to Amphetamine Medication But Not to Methylphenidate, Have Allelic Variants of the SNAP 25 Gene?
This study ended early.
In VancouverADHDObservational studyAges 6+
- Countries
- Canada
- Sponsor
- University of British Columbia
CompletedNCT02694939
Official study titleEffectiveness of MI Enhanced Behavior Therapy for Adolescents With ADHD
This study has finished and is no longer accepting participants.
In MiamiADHDBehavioural studyAges 11–17
- Countries
- United States
- Sponsor
- Florida International University
CompletedNCT02795637
Official study titlePharmacokinetics of Orally Administered Dasotraline in Subjects With Mild, Moderate, and Severe Hepatic Dysfunction
This study has finished and is no longer accepting participants.
Multiple locations, including MiamiADHD, Eating disordersMedication studyAges 18–70
- Countries
- United States
- Sponsor
- Sumitomo Pharma America, Inc.
UnknownNCT06069323
Official study titleTherapeutic Use of Repetitive Transcranial Magnetic Stimulation (rTMS) in Pediatric Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Cohorts (ADHD): a Randomized, Sham-controlled Study.
Current recruitment status is unconfirmed.
In FoggiaADHDDevice studyAges 6–18
- Countries
- Italy
- Sponsor
- Ospedali Riuniti di Foggia
CompletedNCT03437772
Official study titleThird Generation Cognitive Behavioural Therapy Versus Treatment-as-usual for Attention Deficit and Hyperactivity Disorder: a Randomized, 2-parallel-group, Evaluator Blinded, Superiority Trial
This study has finished and is no longer accepting participants.
Multiple locations, including MontpellierADHDObservational studyAges 7–15
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
CompletedNCT07098585
Official study titleAn Open Label, Randomized, Two-period, Two-treatment, Two-sequence, Crossover, Balanced, Single Dose Oral Bioequivalence Study in Healthy Adult Human Subjects Under Fasting Conditions.
This study has finished and is no longer accepting participants.
In AhmedabadADHDMedication studyAges 18–55
- Countries
- India
- Sponsor
- Humanis Saglık Anonim Sirketi